Disparities exist in survival among younger patients with acute leukemia
the ONA take:
Disparities in treatment outcomes for younger patients with acute promyelocytic leukemia (APL) exist among uninsured patients and those of Hispanic and black race/ethnicity, according to a new study published online ahead of print in the journal Cancer.
For the study, researchers sought to evaluate disparities in early death and survival in children, adolescents, and young adults with APL in California in the era of all-trans-retinoic acid (ATRA) treatment.
Researchers analyzed data from the California Cancer Registry to assess the 7-day and 30-day mortality and survival in 772 patients younger than 39 years of age with APL who were diagnosed between 1988 and 2011.
Results showed that the overall 30-day mortality decreased from 26% between 1988 and 1995 to 14% between 2004 and 2011, suggesting that the odds of death in the 30 days after diagnosis were 3 times higher during the first time period than the second time period.
Researchers found that lack of insurance and Hispanic and black race/ethnicity were associated with higher early death and reduced survival, suggesting that efforts should be made to improve access to effective treatment among those patients.
Disparities in treatment outcomes for younger patients with acute promyelocytic leukemia (APL) exist.
- Novel Blood Test Detects Cancer, Locates Tumor Without Invasive Procedures
- Cabozantinib Activates Innate Immune Response, Eliminating Prostate Cancer
- Shorter Treatment of Breast Cancer with Trastuzumab May Lead to Improved Results
- Colorectal Cancer Rates Increased Sharply Among Generation X and Millennials
- Pneumonia Associated With Common Cold May Cause Fatal Illness in Stem Cell Transplant Recipients
- Early Palliative Care Reduced ICU Use in Patients With Advanced Cancer
- Ginger Extract Raises Antioxidant Levels in Patients Undergoing Chemotherapy
- Nurse Navigators Improve Physician Engagement in Pretreatment Discussions
- Screening Increases Early Palliative Care, Reduces Aggressive EOL Measures
- Antiperspirants/Deodorants and Breast Cancer (Fact Sheet)
- Genome Sequencing Explains Resistance to CTLA-4 and PD-1 Inhibitors in Metastatic Melanoma
- Lifestyle Choices Have Greater Influence on Colon and Rectal Cancer Risk
- Kidney Cancer Metastases in Lung May Hide Undiagnosed Primary Lung Cancer
- Nasal Biomarker in Smokers Could Predict Lung Cancer
- Arm Lymphoscintigraphy After Axillary Lymph Node Dissection or Sentinel Lymph Node Biopsy in Breast Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|